OptiBiotix Health (LON:OPTI) Trading 9.6% Higher – Should You Buy?

OptiBiotix Health Plc (LON:OPTI) traded up 9.6% during trading on Thursday . The company traded as high as GBX 6.50 and last traded at GBX 6.30. 597,335 shares were traded during trading, an increase of 26% from the average session volume of 473,704 shares. The stock had previously closed at GBX 5.75.

OptiBiotix Health Stock Performance

The business’s 50 day moving average price is GBX 5.32 and its 200 day moving average price is GBX 6.36. The firm has a market cap of £6.51 million, a price-to-earnings ratio of -209.97 and a beta of 1.71.

OptiBiotix Health (LON:OPTI) last issued its quarterly earnings data on Thursday, May 28th. The company reported GBX (3.84) earnings per share for the quarter. The firm had revenue of GBX 117 million during the quarter. OptiBiotix Health had a negative return on equity of 2.27% and a negative net margin of 16.59%.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.